Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hormone replacement therapy and raloxifene effects on plasmacytoid dendritic cells and B lymphocytes in postmenopausal women
2009-017144-14Phase 2Active
- Sponsor
- Centre hospitalier universitaire de Toulouse
- Start
- Mar 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of estradiol, progesterone and raloxifene in menopause (2 arms), sponsored by Centre hospitalier universitaire de Toulouse. Primary endpoint: Type I interferon production by plasmacytoid dendritic cells. Started Mar 2010; status: active.
02
Drugs
estradiolprogesteroneraloxifene
03
Conditions
menopause
Beyond the preview
Go deeper on 2009-017144-14.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-017144-14.